Living

LCT.AX

Tags: AU Healthcare Biotechnology

Living Cell Technologies Limited Price (LCT.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

0

(100)%

Market Cap of Living (LCT.AX)

Market cap:

As of , LCT.AX has a market cap of . This makes LCT.AX the 1046th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Living Cell Technologies Limited, a biotechnology company, discovers, develops, and commercializes regenerative treatments that use naturally occurring cells to restore functions in Australia and New Zealand. It is developing NTCELL, an alginate-coated capsule, which is in phase IIb clinical trial for the treatment of Parkinson's disease. The company was founded in 1987 and is based in Sydney, Australia. Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.008-0.018
Market Cap 24.53M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Biotechnology

ceo: Mr. David Richard Hainsworth
IPO Date: September, 01, 2004
Country: AU
Currency: AUD
Headquaters: Sydney, NSW
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: